ArticleNPJ precision oncology2024

Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer.

Andrea Boscolo Bragadin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.